There were 2,223 press releases posted in the last 24 hours and 360,083 in the last 365 days.

Integer Schedules First Quarter 2017 Earnings Release and Conference Call for May 8, 2017

FRISCO, Texas, April 19, 2017 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), announced today that it plans to release financial and operational results for the first quarter 2017, after market close on Monday, May 8, 2017. Following the release, Integer management will host a conference call with a live webcast to discuss these results. Other forward-looking and material information may also be discussed during this call.

Conference call details:

  • Date:  Monday, May 8, 2017
  • Time:  5:00 p.m. EDT / 4:00 p.m. CDT
  • Domestic dial-in number:  1-877-201-0168
  • International dial-in number:  1-647-788-4901
  • Conference ID:  1815297

The conference call webcast and subsequent archived replay may be accessed via the following link: http://integer.net.

About Integer™ 
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. The company's brands include GreatbatchTM Medical, Lake Region MedicalTM and ElectrochemTM. Additional information is available at www.integer.net.

Investor Relations:
Amy Wakeham
IR@integer.net
214.618.4978

Media Relations:
Kelly Butler
kelly.butler@integer.net
214.618.4216

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.